Mesoblast Achieves Target of 300 Treated Patients in Pivotal Phase 3 Trial for Chronic Low Back Pain
Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has achieved its target of at least 300 patients treated in ...
Discover how digital underwriting is transforming term life insurance affordability in India, enabling personalized pricing and faster approvals.
Australians are being warned about a range of “sexual enhancement supplements” available online after testing found they ...
Unsplash Every year, researchers and policy analysts try to answer a deceptively simple question: which country actually ...
Preferred vendor status gives private orthodontists priority access, launch pricing, training, and fast delivery ...
Why are you running for this office, and what specifically makes you a better candidate than your opponent? I’m running to ...
Most websites selling GLP-1 receptor agonists prescribe medications without any direct interaction with a health care ...
MEDVi QUAD, also searched as Quad by Medvi, is a telehealth prescription program built for adults comparing private online ...
BrightSpring stock is rated HOLD after a sharp valuation rerating. Q1 Pharmacy Solutions beat on price/mix & LDD deals, but ...
The modern healthcare landscape is in an era where clinical innovation alone no longer guarantees market success. Instead, ...
Scott Poupore has spent more than three decades in the optical business, from trade school in northern Minnesota to Oakley ...
Seven Democrats are on the ballot in Virginia’s 1st Congressional District primary election. They are Elizabeth Dempsey Beggs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results